DENTSPLY SIRONA (NASDAQ:XRAY) PT Lowered to $40.00

DENTSPLY SIRONA (NASDAQ:XRAYGet Rating) had its price objective decreased by equities research analysts at Barrington Research from $51.00 to $40.00 in a note issued to investors on Tuesday, The Fly reports. Barrington Research’s price objective would suggest a potential upside of 30.72% from the stock’s current price.

Several other research analysts have also recently issued reports on XRAY. William Blair reiterated an “underperform” rating on shares of DENTSPLY SIRONA in a report on Tuesday, November 1st. Piper Sandler decreased their price target on shares of DENTSPLY SIRONA from $38.00 to $29.00 in a research report on Monday. The Goldman Sachs Group decreased their price target on shares of DENTSPLY SIRONA from $42.00 to $41.00 and set a “neutral” rating for the company in a research report on Thursday, July 21st. StockNews.com began coverage on shares of DENTSPLY SIRONA in a research report on Wednesday, October 12th. They issued a “hold” rating for the company. Finally, Morgan Stanley decreased their price objective on shares of DENTSPLY SIRONA from $42.00 to $39.00 and set an “overweight” rating for the company in a research report on Tuesday. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the stock. According to MarketBeat, DENTSPLY SIRONA currently has an average rating of “Hold” and a consensus target price of $44.56.

DENTSPLY SIRONA Trading Down 2.4 %

NASDAQ XRAY opened at $30.60 on Tuesday. The company has a current ratio of 1.52, a quick ratio of 1.05 and a debt-to-equity ratio of 0.37. DENTSPLY SIRONA has a 12 month low of $26.48 and a 12 month high of $58.70. The company’s 50-day moving average price is $30.01 and its 200-day moving average price is $34.28. The stock has a market cap of $6.58 billion, a PE ratio of 12.00, a PEG ratio of 3.46 and a beta of 0.95.

DENTSPLY SIRONA (NASDAQ:XRAYGet Rating) last issued its earnings results on Monday, November 14th. The medical instruments supplier reported $0.41 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.59 by ($0.18). DENTSPLY SIRONA had a return on equity of 10.18% and a net margin of 8.27%. The business had revenue of $947.00 million for the quarter, compared to the consensus estimate of $1.01 billion. During the same quarter in the previous year, the company earned $0.68 earnings per share. The firm’s revenue was down 8.9% on a year-over-year basis. Equities research analysts forecast that DENTSPLY SIRONA will post 1.95 earnings per share for the current year.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Macquarie Group Ltd. increased its holdings in DENTSPLY SIRONA by 3.2% in the 2nd quarter. Macquarie Group Ltd. now owns 8,879 shares of the medical instruments supplier’s stock worth $318,000 after buying an additional 274 shares during the period. Crossmark Global Holdings Inc. grew its stake in shares of DENTSPLY SIRONA by 1.7% during the 1st quarter. Crossmark Global Holdings Inc. now owns 17,177 shares of the medical instruments supplier’s stock worth $846,000 after purchasing an additional 280 shares during the period. Park Avenue Securities LLC grew its stake in shares of DENTSPLY SIRONA by 4.6% during the 2nd quarter. Park Avenue Securities LLC now owns 6,403 shares of the medical instruments supplier’s stock worth $229,000 after purchasing an additional 280 shares during the period. Mutual of America Capital Management LLC grew its stake in shares of DENTSPLY SIRONA by 1.1% during the 1st quarter. Mutual of America Capital Management LLC now owns 29,226 shares of the medical instruments supplier’s stock worth $1,439,000 after purchasing an additional 306 shares during the period. Finally, Citizens Financial Group Inc RI grew its stake in shares of DENTSPLY SIRONA by 8.0% during the 1st quarter. Citizens Financial Group Inc RI now owns 4,132 shares of the medical instruments supplier’s stock worth $204,000 after purchasing an additional 307 shares during the period. Institutional investors and hedge funds own 96.00% of the company’s stock.

DENTSPLY SIRONA Company Profile

(Get Rating)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products.

See Also

The Fly logo

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.